
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Molecular Pathology, Institute of Pathology, University of Heidelberg, D-69120 Heidelberg, Germany
To whom requests for reprints should be addressed, at Division of Molecular Pathology, Department of Pathology, University of Heidelberg, Im Neuenheimer Feld 328, D-69120 Heidelberg, Germany. Phone: 49-6221-56-6119; Fax: 49-6221-56-5773; E-mail: susanne_dihlmann{at}med.uni-heidelberg.de
Constitutive activation of the Wnt/ß-catenin pathway is thought to play a central role in colorectal carcinogenesis. A key output in this pathway is the nuclear level of ß-catenin, which determines the transcription of T-cell transcription factor (TCF)/lymphoid enhancer-binding factor-responsive target genes. In unstimulated cells, ß-catenin is continuously targeted for ubiquitin-dependent degradation, which depends on its NH2-terminal phosphorylation by glycogen synthase kinase-3ß (GSK-3ß) in association with a multiprotein complex. Previously, we have shown that the nonsteroidal anti-inflammatory drugs (NSAIDs) aspirin and indomethacin down-regulate ß-catenin/TCF signaling in colorectal cancer cells. Here, we demonstrate that the reduced signaling activity of ß-catenin in response to NSAIDs is a result of its enhanced phosphorylation. In SW948 and SW480 colorectal cancer cells, phosphorylation of NH2-terminal S/T residues time dependently increased in response to aspirin and indomethacin. In contrast, in 293 cells, NSAID treatment failed to induce detectable levels of ß-catenin phosphorylation but resulted in degradation of ß-catenin within 24 h in serum-deprived cells. The aspirin-induced ß-catenin phosphorylation in colon cancer cells preceded down-regulation of ß-catenin/TCF signaling, suggesting a causal relationship. Inhibition of this process by LiCl pointed to participation of GSK-3ß. Unexpectedly, GSK-3ß was also phosphorylated upon aspirin treatment in six colorectal cancer cell lines. We present evidence that inactivation of a phosphatase rather than stimulation of a kinase or interference with the ubiquitination machinery may be the cause of the stabilized phosphorylation. The data emphasize the importance of ß-catenin in the pathogenesis of colorectal cancer and define it as a key target for anticancer therapeutics.
This article has been cited by other articles:
![]() |
J. B. Tuynman, L. Vermeulen, E. M. Boon, K. Kemper, A. H. Zwinderman, M. P. Peppelenbosch, and D. J. Richel Cyclooxygenase-2 Inhibition Inhibits c-Met Kinase Activity and Wnt Activity in Colon Cancer Cancer Res., February 15, 2008; 68(4): 1213 - 1220. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Choi, M. W. Park, S. Y. Lee, M.-Y. Jeon, M. Y. Kim, H. K. Lee, J. Yu, H.-J. Kim, K. Han, H. Lee, et al. Intracellular expression of the T-cell factor-1 RNA aptamer as an intramer. Mol. Cancer Ther., September 1, 2006; 5(9): 2428 - 2434. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lu, H. B. Cottam, M. Corr, and D. A. Carson Repression of {beta}-catenin function in malignant cells by nonsteroidal antiinflammatory drugs PNAS, December 20, 2005; 102(51): 18567 - 18571. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Park, E. R. Hahm, J. H. Lee, K. C. Jung, H. S. Rhee, and C. H. Yang Ionomycin downregulates {beta}-catenin/Tcf signaling in colon cancer cell line Carcinogenesis, November 1, 2005; 26(11): 1929 - 1933. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dihlmann, M. Kloor, C. Fallsehr, and M. von Knebel Doeberitz Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cells Carcinogenesis, September 1, 2005; 26(9): 1503 - 1512. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Fahnert, J. Veijola, G. Roel, M. K. Karkkainen, A. Railo, O. Destree, S. Vainio, and P. Neubauer Murine Wnt-1 with an Internal c-myc Tag Recombinantly Produced in Escherichia coli Can Induce Intracellular Signaling of the Canonical Wnt Pathway in Eukaryotic Cells J. Biol. Chem., November 12, 2004; 279(46): 47520 - 47527. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |